← Leaderboards
Richard Lewis Possemato
New York University School Of Medicine
$6,838,852
Attributed
$6,838,852
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,838,852 · 8
By mechanism
R01$4,894,575 · 3
R00$739,525 · 1
R35$466,125 · 1
R21$405,529 · 1
K99$227,976 · 1
P30$105,122 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Kwok Kin Wong$31,472,345
- Jane Amanda Skok$18,379,753
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellMetabolismResponseCellsPathway InteractionsMalignant NeoplasmsGenesMolecularCancer TherapyOxygenGrantIronMetabolicCofactorAnabolismBaseNutrientRna InterferenceStarvationCell DeathInnovationProteinsGene ExpressionTumor
Grant awards (25)
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy$544,658
R01 · FY2025 · CA · contact PI
Identifying and characterizing metabolic control mechanisms$466,125
R35 · FY2025 · GM · contact PI
Cancer Cell Biology (CCB) Research Program$52,562
P30 · FY2025 · CA · contact PI
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy$544,658
R01 · FY2024 · CA · contact PI
Cancer Cell Biology (CCB) Research Program$52,560
P30 · FY2024 · CA · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$385,928
R01 · FY2023 · GM · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Supplement$55,038
R01 · FY2023 · GM · contact PI
Targeting Metabolic Liabilities in Cancer$390,657
R01 · FY2022 · CA · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$385,928
R01 · FY2022 · GM · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Supplement$68,795
R01 · FY2022 · GM · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$64,076
R01 · FY2022 · GM · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$482,041
R01 · FY2021 · GM · contact PI
Targeting Metabolic Liabilities in Cancer$390,657
R01 · FY2021 · CA · contact PI
Targeting Metabolic Liabilities in Cancer$390,657
R01 · FY2020 · CA · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$389,850
R01 · FY2020 · GM · contact PI
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1$32,037
R01 · FY2020 · GM · contact PI
Targeting Metabolic Liabilities in Cancer$378,938
R01 · FY2019 · CA · contact PI
Targeting Metabolic Liabilities in Cancer$390,657
R01 · FY2018 · CA · contact PI
Identification of Metabolic Liabilities in Breast Cancer$248,999
R00 · FY2016 · CA · contact PI
Rapid Determination of Phenotypic Responses Across Cancer Cell Lines$184,331
R21 · FY2016 · CA · contact PI
Identification of Metabolic Liabilities in Breast Cancer$248,999
R00 · FY2015 · CA · contact PI
Rapid Determination of Phenotypic Responses Across Cancer Cell Lines$221,198
R21 · FY2015 · CA · contact PI
Identification of Metabolic Liabilities in Breast Cancer$241,527
R00 · FY2014 · CA · contact PI
Identification of Metabolic Liabilities in Breast Cancer$113,988
K99 · FY2013 · CA · contact PI
Identification of Metabolic Liabilities in Breast Cancer$113,988
K99 · FY2012 · CA · contact PI